Insmed announces pricing of $750 million public offering of common stock

Bridgewater, n.j. , june 11, 2025 /prnewswire/ -- insmed incorporated (nasdaq: insm), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, today announced that it priced an underwritten public offering of 7,812,500 shares of its common stock at a price to the public of $96.00 per share.
INSM Ratings Summary
INSM Quant Ranking